Perou et al. analyzed the inter-tumor heterogeneity in breast cancer using microarrays and developed a classification system that defined intrinsic subtypes (luminal A, luminal B, HER2-enriched, basal-like, and normal)5. This evidence concerns the gene ERBB2 and breast cancer.